Many patients with chronic inflammatory diseases show accelerated tryptophan degradation and an increased susceptibility for depressive mood, implicating a role of cytokine-induced IDO enzyme activity in psychiatric diseases [41,98]. Here, IDO1 is linked to psychiatric disorder.